Erik L. Ridley and Kate Madden Yee

RSNA 2024
GE HealthCare targets precision care, workflow improvements
A new SPECT/CT system and a range of AI technologies aimed at improving operational efficiencies were among the highlights for GE HealthCare at RSNA 2024.
December 5, 2024
GE HealthCare's new Aurora dual-head SPECT/CT scanner. Image courtesy of GE HealthCare.
2022
Canon highlights U.S. subsidiary, new products at RSNA 2022
CHICAGO - Plans for a new U.S. subsidiary and a range of new product launches were among the highlights for Canon Medical Systems at RSNA 2022.
November 29, 2022
2022 11 30 22 59 1769 2022 11 30 Canon Cxdi Elite 20221130222539
Nuclear Medicine
GE leans into improving patient outcomes, healthcare efficiency
CHICAGO - At this year's RSNA meeting, GE Healthcare is focusing on two goals: improving patient outcomes and boosting the efficiency of the healthcare enterprise. Promotion of these themes comes just weeks before GE is set to spin off its healthcare division into a standalone firm to be called GE HealthCare, which it plans to do in January.
November 28, 2022
2021 11 30 16 39 4000 Ge Rsna 2021 400
Breast
Screening mammography sensitivity is improving, study shows
Breast imagers are doing a better job of detecting breast cancer, according to a study published online May 26 in Radiology that evaluated 2.5 million screening mammograms in the U.S. over a nine-year period.
May 26, 2010
Page 1 of 1
Top Stories
I-123 MIBG–negative and F-18 MFBG–positive scans showing multiple lesions in 9-year-old male with relapsed high-risk, multiple-relapse neuroblastoma (stage IV disease) receiving chemoimmunotherapy. (A) I-123 MIBG uptake is seen in lower lumbar vertebrae (arrows). Positive uptake with F-18 MFBG PET (B; black arrows) in skull, spine, pelvic bones, femora, and left tibia (B and C; blue and white arrows). Bone marrow biopsy was positive for disease. Follow-up I-123 MIBG imaging (D; left) and spine MRI (D; right) performed six weeks later showed diffuse disease in skull and spine, corresponding to F-18 MFBG–avid sites.
Molecular Imaging
PET tracer shows promise in patients with neuroblastoma
The PET tracer performed better than standard SPECT imaging with iodine-123 metaiodobenzylguanidine.
Contrast Injector
CT
ISCT: 2022 ICM shortage was a 'wake-up call.' Did we listen?
Flower Chrysanthemum 400
Imaging Leaders
Radiology world mourns passing of Leonard Berlin
Klebsiella Adobe Zachary
CT
Revealed: The cause of CT safety incident in Belgium
"Join Us"
Sponsor Content
"Join Us"
More in Home
PET tracer shows promise in patients with neuroblastoma
By Will Morton
The PET tracer performed better than standard SPECT imaging with iodine-123 metaiodobenzylguanidine.
September 4, 2025
I-123 MIBG–negative and F-18 MFBG–positive scans showing multiple lesions in 9-year-old male with relapsed high-risk, multiple-relapse neuroblastoma (stage IV disease) receiving chemoimmunotherapy. (A) I-123 MIBG uptake is seen in lower lumbar vertebrae (arrows). Positive uptake with F-18 MFBG PET (B; black arrows) in skull, spine, pelvic bones, femora, and left tibia (B and C; blue and white arrows). Bone marrow biopsy was positive for disease. Follow-up I-123 MIBG imaging (D; left) and spine MRI (D; right) performed six weeks later showed diffuse disease in skull and spine, corresponding to F-18 MFBG–avid sites.
ISCT: 2022 ICM shortage was a 'wake-up call.' Did we listen?
By Kate Madden Yee
In 2022, the global supply chain for ICM was disrupted by COVID lockdowns -- and this kind of crisis will likely occur again.
September 4, 2025
Contrast Injector
Radiology world mourns passing of Leonard Berlin
By Amerigo Allegretto
The radiology world is mourning the loss of Leonard Berlin, MD, a leading voice on the intersection between medicine and malpractice.
September 4, 2025
Flower Chrysanthemum 400
Revealed: The cause of CT safety incident in Belgium
By Edna Astbury-Ward, PhD
A single bottle of contaminated contrast agent was the cause of eight patients' illness after undergoing CT in Belgium.
September 4, 2025
Klebsiella Adobe Zachary
Agentic AI as the new infrastructure for interoperability
By Rishi Nayyar
Agentic AI can improve interoperability in imaging, according to a column by PocketHealth Co-founder and CEO Rishi Nayyar.
September 3, 2025
Nayyar Rishi Thumbnail
AI interpretation leads to high NPV, recall rates in breast imaging
By Amerigo Allegretto
In a new study, an AI system reached near-perfect negative predictive value (NPV) in breast imaging but almost doubled the recall rate.
September 3, 2025
2025 09 03 Ajr Ai Breast Images Thumbnail
How does practice consolidation affect radiology services pricing?
By Kate Madden Yee
Hospital and private equity-affiliated radiology practices charge more for radiologic services compared with independent practices.
September 3, 2025
Medical Bill Final Notice
Coming soon? 'Regenerative imaging'
By Liz Carey
A CRISPR/Cas9 gene imaging system advances the field of regenerative imaging for stem cell tracking in stroke.
September 2, 2025
2025 09 02 Crispr Cas9 Thumbnail
Combination of osmotically active agents improve drug delivery to brain
By Will Morton
MRI and PET showed that a combination of osmotically active agents safely increased blood-brain barrier permeability in mice.
September 2, 2025
2025 09 02 Pet Bbb Thumbnail
Follow-up analysis shows ELCAP's continued efficacy for CVD prediction
By Kate Madden Yee
Follow-up analysis of the ELCAP-CAC scoring system has shown it to be effective for predicting death from cardiovascular disease (CVD).
September 2, 2025
Chest Heart Pain
Node-RADS evaluates breast cancers on MRI exams
By Amerigo Allegretto
Node-RADS showed promising results for evaluating invasive ductal and lobular breast cancers.
September 2, 2025
2025 09 02 Radiology Idc Ilc Noderads Thumbnail A
UnitedHealthcare alleges billing fraud in new RP lawsuit
By Liz Carey
Pass-through billing has come up again in a new lawsuit alleging RP funneled in-network claims through a "sham out-of-network entity."
August 29, 2025
Radiology Partners Lawsuit August 2025 Thumbnail
Page 1 of 168
Next Page